Meeting NewsVideo

VIDEO: Bimatoprost SR shows visual field preservation, IOP control

VANCOUVER, British Columbia — Yehia Hashad, MD, Allergan’s senior vice president and head of global development, discusses a recent study that found the company’s sustained release bimatoprost implant provided good IOP control and visual field preservation in patients with open-angle glaucoma.

VANCOUVER, British Columbia — Yehia Hashad, MD, Allergan’s senior vice president and head of global development, discusses a recent study that found the company’s sustained release bimatoprost implant provided good IOP control and visual field preservation in patients with open-angle glaucoma.

    See more from Association for Research in Vision and Ophthalmology